HTG Introduces new Product to Measure MicroRNA
News Jan 07, 2009
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, has announced the availability of a customizable qNPA™ ArrayPlate to measure microRNA or other small RNA molecules.
The customizable platform simplifies the workflow of gene expression analysis. It does not require the process of RNA extraction for measurement. qNPA measures the changes in gene expression due to the functional biology not as a consequence of the RNA extraction technique. Currently, most identified miRNAs can be measured with the qNPA ArrayPlate technology for human, rat, and mouse.
“HTG devised this functionality at the request of customers who have long sought a miRNA analysis solution that was quick, accurate, sensitive and reliable,” said TJ Johnson, president and CEO, HTG. “As such, HTG remains committed to enabling pharmaceutical and academic researchers to effectively screen drug compounds across hundreds to thousands of samples to help identify and move the most promising drug compounds through the research process.”
The new customizable qNPA ArrayPlate offering also allows researchers to measure miRNA and mRNA simultaneously in the same sample well.
The product is based on HTG’s qNPA ArrayPlate technology platform, which allows researchers to investigate a customized set of genes with precision.
HTG’s qNPA technology is used to carry out quantitative, multiplexed gene-based drug discovery programs, including target validation, HTS lead optimization, metabolism, toxicology and clinical development.
HTG’s platform is designed for high throughput automation; it allows scientists to test any sample, including fixed tissues, without RNA extraction or target amplification.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018